Swisslog Healthcare has acquired West Coast medication management company Talyst. Starting in 2018, the companies will begin integrating their pharmacy systems to address a large customer base in North America.
“The two companies share a similar mission and vision and the Talyst portfolio of enterprise software and pharmacy automation products completes Swisslog Healthcare’s pharmacy automation offering in North America,” said Swisslog Healthcare CEO Stephan Sonderegger. “This acquisition adds critical components to our solutions strategy of providing customers with end-to-end integration for the medication supply chain across the continuum of care.”
The vast majority of Talyst employees will be brought into Swisslog North America.
Swisslog, which is erecting a new building in Denver, also will retain the Talyst building and facility in Kirkland, WA. It plans to integrate the Dallas Talyst office into its own office there, according to Stead Broadwell, a board member and managing director of Columbia Pacific Advisors, which bought Talyst in 2015.
He told McKnight’s the strategic deal made sense given how Swisslog Healthcare “is a global leader in healthcare and software systems design.”
“There are two important trends that are happening that Swisslog can take advantage of. One is in skilled nursing and the increasing recognition of high-acute facilities that need advanced automation solutions to improve patient care. Talyst Insite Care is scaling nicely because there has become broader regulatory approval,” Broadwell said.
Talyst CEO Carla Corkern will not join the new company, with Corkern writing on LinkedIn that it had been “an honor and a privilege to lead the organization and witness its industry impact and corporate growth.” Terms of the deal were not disclosed.